Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $5.17 is 4.66% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 5.695||$ 38.46|
|Low:||$ 5.12||$ 4.94|
Company Description (as filed with the SEC)
We are a latestage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using our proprietary PRINT® technology to transform the lives of patients. PRINT is a particle engineering platform that enables precise production of uniform drug particles designed to improve the safety, efficacy and performance of a wide range of therapies. We are currently focused on the development of two product candidates for which we hold worldwide commercial rights: LIQ861 for the treatment of pulmonary arterial hypertension, or PAH, and LIQ865 for the treatment of local postoperative pain. Our lead product candidate, LIQ861, is being evaluated in an openlabel Phase 3 clinical trial. LIQ861 is an inhaled dry powder formulation of treprostinil designed to improve the therapeutic profile of treprostinil by enhancing deeplung delivery and achieving higher dose levels than current inhaled therapies. ... More ...
Nasdaq Official Price
Aug. 23, 2019
Aug. 23, 2019